secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nutex Health Inc. (NUTX)
CIK:        0001479681
Form:       8-K
Filed at:   2025-11-18T23:59:59+00:00
Accession:  0001628280-25-052952
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutex Health restates Q1 2025: revenue $211.8M, net income $21.2M, diluted EPS $3.33
--------------------------------------------------------------------------------

- Total revenue $211.8M, up 214% YoY from $67.5M.
- Net income attributable to Nutex $21.2M vs net loss $0.4M in Q1 2024.
- Diluted EPS $3.33 vs loss per share $0.08.
- Adjusted EBITDA $72.8M vs $(0.4)M prior year.
- Net cash from operating activities of $51.0M for Q1 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479681/000162828025052952/0001628280-25-052952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479681/000162828025052952/nutx-20251118.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-052952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer